193 related articles for article (PubMed ID: 11434875)
1. Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?
Mannello F; Gazzanelli G
Breast Cancer Res; 2001; 3(4):238-43. PubMed ID: 11434875
[TBL] [Abstract][Full Text] [Related]
2. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
[TBL] [Abstract][Full Text] [Related]
3. The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
Becker C; Noldus J; Diamandis E; Lilja H
Crit Rev Clin Lab Sci; 2001 Oct; 38(5):357-99. PubMed ID: 11720279
[TBL] [Abstract][Full Text] [Related]
4. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions.
Black MH; Magklara A; Obiezu C; Levesque MA; Sutherland DJ; Tindall DJ; Young CY; Sauter ER; Diamandis EP
Br J Cancer; 2000 Jan; 82(2):361-7. PubMed ID: 10646889
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast.
Black MH; Diamandis EP
Breast Cancer Res Treat; 2000 Jan; 59(1):1-14. PubMed ID: 10752675
[TBL] [Abstract][Full Text] [Related]
6. Serum total and free prostate-specific antigen for breast cancer diagnosis in women.
Black MH; Giai M; Ponzone R; Sismondi P; Yu H; Diamandis EP
Clin Cancer Res; 2000 Feb; 6(2):467-73. PubMed ID: 10690525
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen detection by ultrasensitive assay in samples from women.
Filella X; Molina R; Alcover J; Menéndez V; Giménez N; Jo J; Carretero P; Ballesta AM
Prostate; 1996 Nov; 29(5):311-6. PubMed ID: 8899004
[TBL] [Abstract][Full Text] [Related]
8. The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasia.
Saedi MS; Hill TM; Kuus-Reichel K; Kumar A; Payne J; Mikolajczyk SD; Wolfert RL; Rittenhouse HG
Clin Chem; 1998 Oct; 44(10):2115-9. PubMed ID: 9761243
[TBL] [Abstract][Full Text] [Related]
9. Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues.
Olsson AY; Bjartell A; Lilja H; Lundwall A
Int J Cancer; 2005 Jan; 113(2):290-7. PubMed ID: 15389512
[TBL] [Abstract][Full Text] [Related]
10. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
[TBL] [Abstract][Full Text] [Related]
11. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.
Zhao Y; Verselis SJ; Klar N; Sadowsky NL; Kaelin CM; Smith B; Foretova L; Li FP
J Clin Oncol; 2001 Mar; 19(5):1462-7. PubMed ID: 11230492
[TBL] [Abstract][Full Text] [Related]
12. [Possible value of positive PSA levels in malignant and nonmalignant breast diseases].
Schuff-Werner P; Zingler C
Onkologie; 2001 Feb; 24 Suppl 1():11-7. PubMed ID: 11441307
[TBL] [Abstract][Full Text] [Related]
13. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY
Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen and new related markers for prostate cancer.
Daher R; Beaini M
Clin Chem Lab Med; 1998 Sep; 36(9):671-81. PubMed ID: 9804390
[TBL] [Abstract][Full Text] [Related]
15. Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid.
Magklara A; Scorilas A; López-Otín C; Vizoso F; Ruibal A; Diamandis EP
Clin Chem; 1999 Oct; 45(10):1774-80. PubMed ID: 10508124
[TBL] [Abstract][Full Text] [Related]
16. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA.
Magklara A; Scorilas A; Catalona WJ; Diamandis EP
Clin Chem; 1999 Nov; 45(11):1960-6. PubMed ID: 10545066
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen: a cancer fighter and a valuable messenger?
Diamandis EP
Clin Chem; 2000 Jul; 46(7):896-900. PubMed ID: 10894830
[TBL] [Abstract][Full Text] [Related]
18. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.
Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG
Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595
[TBL] [Abstract][Full Text] [Related]
19. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
[TBL] [Abstract][Full Text] [Related]
20. Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.
Sauter ER; Tichansky DS; Chervoneva I; Diamandis EP
Environ Health Perspect; 2002 Mar; 110(3):241-6. PubMed ID: 11882474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
